Logo Image
Commentary|Articles|September 17, 2025

Letters From White House Could Encourage Some Compliance With Most-Favored-Nation Executive Order, Broad Agreements Unlikely: Q&A With Kathy Oubre, MS

New demands to follow the most favored nation executive order could lead to some compliance but it is unknown just how effective they will be across all health care.

In the second part of her Q&A, Kathy Oubre, MS, discusses the recent updates surrounding the most favored nation (MFN) executive order, including how the discussion of tariffs might play into drug pricing and the recent letters that President Donald Trump sent to pharmaceutical companies in July to demand more swift action on the executive order.